LEMAITRE VASCULAR INC — Director's Dealing 2020

Feb 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2020-02-20

Reporting Person: Kamke Trent G (Senior V. P., Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-20	Common Stock	M	2858	$7.87	Acquired	34440	Direct
2020-02-20	Common Stock	M	10979	$11.43	Acquired	45419	Direct
2020-02-20	Common Stock	M	4168	$14.13	Acquired	49587	Direct
2020-02-20	Common Stock	S	14225	$31	Disposed	35362	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-20	Stock Option (Right to Buy)	$7.87	M	2858	Disposed	2021-07-24	Common Stock (2858)	Direct
2020-02-20	Stock Option (Right to Buy)	$11.43	M	10979	Disposed	2022-07-23	Common Stock (10979)	Direct
2020-02-20	Stock Option (Right to Buy)	$14.13	M	4168	Disposed	2023-07-25	Common Stock (4168)	Direct

Footnotes

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

F2: This option is fully vested and exercisable.

F3: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.